Intel shares have retraced roughly 17% since the company’s late-January earnings report, a pullback that analysts viewed as unsurprising given the outsized gains earlier in the cycle. After rallying more than 130% off the August 2025 trough, much of Intel’s AI-driven recovery appears fully discounted in the share price, leaving investors to question whether any further upside remains until new positive catalysts emerge.

In its Q4 results, Intel reported revenue and non-GAAP earnings roughly in line with conservative forecasts, but its Q1 FY2026 guidance missed consensus. Management projected a year-over-year decline in quarterly revenue and a contraction in gross margin, citing persistent supply constraints that are only expected to abate in the April–June quarter. The shortfall underscores the difficulty of balancing robust demand with production bottlenecks tied to legacy and advanced process nodes.

Despite supply headwinds, Intel’s Data Center and AI (DCAI) segment delivered a 15% sequential increase in Q4 revenue, driven by hyperscaler purchases of Xeon chips and strategic wins in custom AI accelerators. However, the company cautioned that the FY2026 recovery will be bumpy. Ramp plans for next-generation foundry nodes hinge on customer commitments, and margin expansion may be delayed until manufacturing yields improve and wafer inventories stabilize in the back half of the year.